Foamlab
Develops and manufactures bacterial cellulose foam materials designed to replace fossil-based plastics across industrial and consumer foam applications.
Overview
Foamlab develops bacterial cellulose foam materials intended as biobased replacements for fossil-derived plastics. The company targets industrial and consumer users of foam products and positions its materials as an alternative to petrochemical foams across multiple use cases. Based in Delft, Foamlab centers its differentiation on using bacterial cellulose as the core material, offering a biologically produced foam rather than synthetic polymers. The company completed a €3 million growth capital round in April 2026, its only disclosed financing to date, to advance development and commercial deployment.
Funding History
Delft’s Foamlab raises €3 million to replace fossil-based plastics with its bacterial cellulose foams
Frequently Asked Questions
- How much has Foamlab raised in total?
- Foamlab has raised a total of $3M across 1 funding round.
- Who are Foamlab's investors?
- Foamlab's investors include Undisclosed.
- What does Foamlab do?
- Foamlab develops bacterial cellulose foam materials intended as biobased replacements for fossil-derived plastics. The company targets industrial and consumer users of foam products and positions its materials as an alternative to petrochemical foams across multiple use cases. Based in Delft, Foamlab centers its differentiation on using bacterial cellulose as the core material, offering a biologically produced foam rather than synthetic polymers. The company completed a €3 million growth capital round in April 2026, its only disclosed financing to date, to advance development and commercial deployment.
- Where is Foamlab headquartered?
- Foamlab is headquartered in Delft, Netherlands.
Investors
Related Insights
A comprehensive analysis of Tropic Biosciences's funding history, investors, competitive position, and growth trajectory in the Deep Tech space.
A comprehensive analysis of Hebbia's funding history, investors, competitive position, and growth trajectory in the Enterprise AI space.
An in-depth analysis of Lux Capital's AI investment portfolio, strategy, co-investors, and sector focus across 4 tracked deals.